SCHEMBL20867089

SCHEMBL20867089

Cc1ccccc1C(=N)OC(=N)NC1N=C(c2ccccc2)c2ccccc2NC1=O

nearest known ligand 0.58

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CCKBR P32239 17/20 0.58
▸ CCKAR P32238 12/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20866689 0.89 CCKBR (0.56) CCKBRCCKAR
SCHEMBL20866968 0.88 CCKBR (0.58) CCKBRCCKAR
SCHEMBL20867087 0.88 CCKBR (0.58) CCKBRCCKAR
SCHEMBL20866649 0.87 CCKBR (0.74) CCKBRCCKAR
SCHEMBL24611973 0.87 CCKBR (0.61) CCKBRCCKAR
SCHEMBL20866819 0.87 CCKBR (0.63) CCKBRCCKAR
SCHEMBL20866767 0.87 CCKBR (0.56) CCKBRCCKAR
SCHEMBL20866659 0.87 CCKBR (0.62) CCKBRCCKAR
SCHEMBL24612037 0.85 CCKBR (0.53) CCKBRCCKAR
SCHEMBL20867015 0.85 CCKBR (0.58) CCKBRCCKAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3324977-B1 BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS ENANTA PHARM INC (US) 2022-07-13 — — EP disclosed
WO-2019067864-A1 COMBINATION PHARMACEUTICAL AGENTS AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2019-04-04 — — WO disclosed
Send feedback